An observational study in Bacteremia, sponsored by Assistance Publique - Hôpitaux de Paris. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-09-21.
Sponsored by Assistance Publique - Hôpitaux de Paris · Observational
The primary objective of the study is to identify the risk factors of community-acquired bacteremia to resistant bacteria.
As the secondary objectives, the study aims
The investigators will study in particularly individual exposure to antibiotics: exposure in 3 months ou in 12 months, cumulative exposure, hospital- and community-acquired exposure, etc.
297 studies on the registry are indexed under Bacteremia; 51 are open to participants now.
This study's planned enrollment of 45,000 is above the median of 300 across 125 observational studies indexed under Bacteremia.
Browse Bacteremia studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Bacteremia cohort: all inpatient patients in a hospital of APHP between January 2010 and december 2018 with at least one haemoculture positive.
Control cohort: patients cared in a hospital of APHP between 2010 and 2018 without infection.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
For bacteraemia cohort:
All inpatient patients in a hospital of APHP between January 2010 and december 2018 with at least one haemoculture positive.
For control cohort:
Patients cared in a hospital of APHP between 2010 and 2018 without infection. - Patients without infection of CIM-10 bacteraemia as primary diagnosis, related diagnosis and associated diagnosis, without haemoculture positive in microbiology.
Exclusion Criteria:
Incidence of bacteraemia
Time frame: through study completion, an average of 3 months
Mortality
Events of death will be recorded, the mortality rate will be calculated for 30 day and 90 day.
Time frame: at 30 day and 90 day
Rehospitalization
The rate of 12 months unplanned rehospitalization for infection by the same biological pathogenes was recorded.
Time frame: 12 months
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →